Frank X Leonard

EVP, Pres., Novocure Oncology

Frank X Leonard (EVP, Pres., Novocure Oncology) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in NVCR. The largest single filing was $615K of NVCR (34,273 sh × $17.93, as filed), executed Jun 4.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 2 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$747K

shares × price, as filed

Last traded

Jun 4

Filed Jun 5

Open performance→

Volume by month

Buys $0 Sells $1.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Not on file 2 filings

Sector per market data · by filing · past 12 months

Most traded names

NVCR NVCR NVCR · 0 buys · 5 sells 5 filings

Recent filings

NVCRSALE NovoCure Ltd View filing → $615K
34,273 sh × $17.93
Exec Jun 4
Filed Jun 5 · 5:30 PM ET NVCRSALE NovoCure Ltd View filing → $133K
9,734 sh × $13.66
Exec Feb 27
Filed Mar 3 · 5:30 PM ET NVCRSALE NovoCure Ltd View filing → $493K
28,317 sh across 2 lots
Exec Jun 2 2025
Filed Jun 4 2025 · 5:30 PM ET NVCRSALE NovoCure Ltd View filing → $205K
10,277 sh × $19.92
Exec Feb 27 2025
Filed Mar 3 2025 · 5:30 PM ET NVCRSALE NovoCure Ltd View filing → $205K
10,277 sh × $19.92
Exec Feb 27 2025
Filed Mar 3 2025 · 5:30 PM ET